Go Pro

Life360 (LIFX) Financials

$14.60 0.00 (0.00%)
As of 09/11/2026
Annual Income Statements for Life360

Annual Income Statements for Life360

This table shows Life360's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-16 -34 -92 -28 -4.56 151
Consolidated Net Income / (Loss)
-16 -34 -92 -28 -4.56 151
Net Income / (Loss) Continuing Operations
-16 -34 -92 -28 -4.56 151
Total Pre-Tax Income
-16 -34 -91 -28 -4.63 33
Total Operating Income
-17 -32 -94 -30 -7.98 19
Total Gross Profit
65 90 149 223 279 381
Total Revenue
81 113 228 305 371 489
Operating Revenue
81 113 228 305 371 489
Total Cost of Revenue
15 23 80 82 92 109
Operating Cost of Revenue
15 23 80 82 92 109
Total Operating Expenses
82 122 243 253 287 362
Selling, General & Admin Expense
12 24 48 53 61 79
Marketing Expense
30 47 92 99 113 155
Research & Development Expense
40 51 102 101 113 128
Total Other Income / (Expense), net
0.32 -1.42 3.09 2.43 3.35 14
Interest Expense
- - 0.00 0.00 0.44 0.00
Interest & Investment Income
- - - 3.08 6.01 14
Other Income / (Expense), net
0.32 -1.42 3.09 -0.66 -2.22 0.13
Income Tax Expense
0.00 -0.13 0.31 0.62 -0.07 -118
Basic Earnings per Share
($0.33) ($0.65) ($1.47) ($0.42) ($0.06) $1.95
Weighted Average Basic Shares Outstanding
49.35M 51.66M 62.21M 66.75M 72.13M 77.25M
Diluted Earnings per Share
($0.33) ($0.65) ($1.50) ($0.42) ($0.06) $1.77
Weighted Average Diluted Shares Outstanding
49.35M 51.66M 62.84M 66.75M 72.13M 85.17M
Weighted Average Basic & Diluted Shares Outstanding
- - 66.27M 68.29M 75.53M 80.20M

Quarterly Income Statements for Life360

This table shows Life360's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-3.15 -9.78 -11 7.69 8.50 4.38 7.01 9.79 130 2.78 5.06
Consolidated Net Income / (Loss)
-3.15 -9.78 -11 7.69 8.50 4.38 7.01 9.79 130 2.78 5.06
Net Income / (Loss) Continuing Operations
-3.15 -9.78 -11 7.69 8.50 4.38 7.01 9.79 130 2.78 5.06
Total Pre-Tax Income
-2.74 -8.38 -5.49 2.96 6.28 4.16 6.61 10 12 -8.91 1.08
Total Operating Income
-4.34 -6.38 -2.36 -4.95 5.72 2.19 1.99 5.69 8.95 -8.08 -0.06
Total Gross Profit
60 60 64 70 86 84 91 97 110 111 127
Total Revenue
87 78 85 93 116 104 115 124 146 143 159
Operating Revenue
87 78 85 93 116 104 115 124 146 143 159
Total Cost of Revenue
27 18 21 23 30 20 25 27 36 33 32
Operating Cost of Revenue
27 18 21 23 30 20 25 27 36 33 32
Total Operating Expenses
64 66 66 75 80 81 89 91 101 119 127
Selling, General & Admin Expense
13 14 15 15 16 16 17 20 26 22 27
Marketing Expense
26 25 24 31 34 35 39 39 42 57 52
Research & Development Expense
26 27 27 29 30 30 32 32 33 39 47
Total Other Income / (Expense), net
1.61 -2.00 -3.12 7.91 0.56 1.98 4.62 4.53 2.71 -0.83 1.14
Interest & Investment Income
- - - 2.07 - 1.78 2.55 4.71 - 3.82 4.18
Other Income / (Expense), net
1.61 -2.00 -2.68 5.84 0.56 0.19 2.08 -0.18 -6.29 -4.64 -3.04
Income Tax Expense
0.41 1.39 5.48 -4.73 -2.22 -0.21 -0.39 0.43 -118 -12 -3.98
Basic Earnings per Share
($0.04) ($0.14) ($0.15) $0.10 $0.13 $0.06 $0.09 $0.13 $1.67 $0.03 $0.06
Weighted Average Basic Shares Outstanding
66.75M 68.54M 70.76M 74.23M 72.13M 75.70M 76.80M 77.74M 77.25M 80.15M 81.00M
Diluted Earnings per Share
($0.04) ($0.14) ($0.15) $0.09 $0.14 $0.05 $0.08 $0.11 $1.53 $0.03 $0.06
Weighted Average Diluted Shares Outstanding
66.75M 68.54M 70.76M 82.08M 72.13M 83.45M 84.48M 85.79M 85.17M 85.68M 85.59M
Weighted Average Basic & Diluted Shares Outstanding
68.29M 69.63M 74.14M 74.67M 75.53M 76.53M 77.55M 78.40M 80.20M 81.03M 81.48M

Annual Cash Flow Statements for Life360

This table details how cash moves in and out of Life360's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-7.46 175 -141 -20 90 335
Net Cash From Operating Activities
-7.25 -12 -57 7.52 33 89
Net Cash From Continuing Operating Activities
-7.25 -12 -57 7.52 33 89
Net Income / (Loss) Continuing Operations
-16 -34 -92 -28 -4.56 151
Consolidated Net Income / (Loss)
-16 -34 -92 -28 -4.56 151
Depreciation Expense
0.66 0.88 9.20 9.14 9.78 13
Amortization Expense
7.02 4.01 2.93 2.97 1.60 1.65
Non-Cash Adjustments To Reconcile Net Income
2.83 12 28 35 34 55
Changes in Operating Assets and Liabilities, net
-1.42 4.88 -5.99 -11 -7.96 -132
Net Cash From Investing Activities
-0.65 -7.06 -112 -2.22 -10 -35
Net Cash From Continuing Investing Activities
-0.65 -7.06 -112 -2.22 -10 -35
Purchase of Property, Plant & Equipment
-0.65 -0.08 -0.70 -2.22 -5.13 -7.51
Acquisitions
0.00 -2.98 -111 0.00 0.00 -2.83
Purchase of Investments
- - - 0.00 0.00 -25
Other Investing Activities, net
0.00 -4.00 0.00 0.00 -5.00 0.00
Net Cash From Financing Activities
0.45 194 28 -25 67 282
Net Cash From Continuing Financing Activities
0.45 194 28 -25 67 282
Repayment of Debt
-3.12 -0.04 -2.82 -3.61 0.00 -11
Repurchase of Common Equity
- - 0.00 0.00 -6.29 0.00
Issuance of Debt
3.12 2.11 - 0.00 0.00 320
Issuance of Common Equity
0.00 193 0.00 0.00 93 0.00
Other Financing Activities, net
0.45 -1.18 31 -21 -19 -27
Cash Interest Paid
0.00 0.02 0.51 0.64 0.05 0.00
Cash Income Taxes Paid
0.00 0.03 0.00 0.70 2.38 -0.89

Quarterly Cash Flow Statements for Life360

This table details how cash moves in and out of Life360's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
7.06 3.89 87 -1.83 0.27 9.90 264 23 39 -143 -83
Net Cash From Operating Activities
8.96 11 3.25 6.35 12 12 13 26 37 17 24
Net Cash From Continuing Operating Activities
8.96 11 3.25 6.35 12 12 13 26 37 17 24
Net Income / (Loss) Continuing Operations
-3.15 -9.78 -11 7.69 8.50 4.38 7.01 9.79 130 2.78 5.06
Consolidated Net Income / (Loss)
-3.15 -9.78 -11 7.69 8.50 4.38 7.01 9.79 130 2.78 5.06
Depreciation Expense
2.30 2.30 2.37 2.40 2.72 2.86 3.07 3.93 3.47 5.42 5.63
Amortization Expense
0.50 0.42 0.40 0.40 0.38 0.37 0.40 0.43 0.45 0.45 0.45
Non-Cash Adjustments To Reconcile Net Income
10 8.15 6.69 5.50 12 9.55 14 14 17 20 24
Changes in Operating Assets and Liabilities, net
-1.08 9.60 4.75 -9.63 -11 -5.09 -11 -2.15 -114 -12 -11
Net Cash From Investing Activities
-0.96 -1.09 -1.23 -0.97 -6.84 -4.35 -28 -1.84 -1.41 -164 -93
Net Cash From Continuing Investing Activities
-0.96 -1.09 -1.23 -0.97 -6.84 -4.35 -28 -1.84 -1.41 -164 -109
Purchase of Property, Plant & Equipment
-0.96 -1.09 -1.23 -0.97 -1.84 -1.52 -2.74 -1.84 -1.41 -1.59 -0.96
Purchase of Investments
- - - - - 0.00 - - - -106 -108
Net Cash From Financing Activities
-0.94 -5.71 85 -7.21 -5.21 2.18 278 -1.61 3.21 3.41 -14
Net Cash From Continuing Financing Activities
-0.94 -5.71 85 -7.21 -5.21 2.18 278 -1.61 3.21 3.41 0.97
Other Financing Activities, net
-0.94 -5.71 -5.77 -6.32 -1.64 2.18 -32 -0.33 3.21 3.41 0.97
Cash Income Taxes Paid
0.16 0.06 1.60 0.67 0.06 0.00 0.03 0.09 -1.01 -0.63 1.09

Annual Balance Sheets for Life360

This table presents Life360's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
302 340 322 442 960
Total Current Assets
257 143 131 241 606
Cash & Equivalents
231 75 69 159 494
Restricted Cash
0.00 13 - - 0.00
Short-Term Investments
- - - - 0.00
Accounts Receivable
12 33 42 58 81
Inventories, net
2.01 11 4.10 8.06 9.87
Prepaid Expenses
11 8.55 15 15 20
Other Current Assets
1.32 1.44 1.01 1.10 1.21
Plant, Property, & Equipment, net
0.58 0.39 0.73 1.78 3.02
Total Noncurrent Assets
45 197 190 199 351
Goodwill
31 134 134 134 135
Intangible Assets
7.99 53 45 41 38
Noncurrent Deferred & Refundable Income Taxes
- - - 0.00 126
Other Noncurrent Operating Assets
6.00 10 10 25 51
Total Liabilities & Shareholders' Equity
302 340 322 442 960
Total Liabilities
52 95 75 83 412
Total Current Liabilities
41 88 71 77 97
Accounts Payable
3.25 14 5.90 5.46 8.41
Accrued Expenses
11 27 28 32 42
Current Deferred Revenue
14 30 34 40 46
Total Noncurrent Liabilities
11 7.44 3.84 5.70 315
Long-Term Debt
8.28 4.06 1.06 0.00 310
Noncurrent Deferred Revenue
0.00 2.71 1.84 5.34 4.33
Other Noncurrent Operating Liabilities
2.60 0.68 0.94 0.36 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
250 245 247 359 548
Total Preferred & Common Equity
250 245 247 359 548
Total Common Equity
250 245 247 359 548
Common Stock
416 502 532 648 687
Retained Earnings
-165 -257 -285 -290 -139
Treasury Stock
- - - - 0.00
Accumulated Other Comprehensive Income / (Loss)
0.00 -0.01 0.01 0.04 0.05

Quarterly Balance Sheets for Life360

This table presents Life360's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
321 312 316 319 406 427 455 754 787 1,041 1,052
Total Current Assets
126 118 125 131 218 235 250 521 557 590 599
Cash & Equivalents
61 62 62 73 161 159 169 433 456 351 267
Restricted Cash
13 0.00 0.00 - - - - - - - 1.00
Short-Term Investments
- - - - - - - - - 106 198
Accounts Receivable
31 33 40 37 41 49 52 59 66 95 99
Inventories, net
8.80 10 11 6.34 5.55 14 9.57 9.67 14 15 15
Prepaid Expenses
10 9.90 11 14 11 13 18 19 20 21 19
Other Current Assets
1.35 1.35 1.08 0.96 0.96 1.04 1.18 1.23 1.26 1.18 1.15
Plant, Property, & Equipment, net
0.76 0.83 0.80 0.68 1.75 1.78 2.60 3.04 3.18 2.89 2.74
Total Noncurrent Assets
195 193 191 187 186 190 203 229 227 448 450
Goodwill
134 134 134 134 134 134 135 135 135 174 174
Intangible Assets
51 49 47 44 44 42 43 43 40 82 77
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - - - 145 149
Other Noncurrent Operating Assets
10 11 9.79 8.68 8.57 14 25 52 53 48 49
Total Liabilities & Shareholders' Equity
321 312 316 319 406 427 455 754 787 1,041 1,052
Total Liabilities
86 74 76 79 79 88 79 387 396 443 438
Total Current Liabilities
81 69 73 74 78 85 74 73 82 110 107
Accounts Payable
9.52 7.11 13 9.39 10 19 5.21 2.97 8.89 22 16
Accrued Expenses
23 24 23 25 32 28 27 27 27 40 43
Current Deferred Revenue
30 31 34 36 35 38 42 43 46 48 48
Total Noncurrent Liabilities
5.70 5.40 3.41 4.92 1.60 2.42 5.11 314 314 333 331
Long-Term Debt
2.81 1.92 0.95 1.16 0.00 0.00 - 309 310 311 311
Noncurrent Deferred Revenue
2.31 1.76 1.37 1.20 0.94 1.97 4.85 4.51 4.16 3.73 3.31
Other Noncurrent Operating Liabilities
0.58 1.72 1.09 2.56 0.66 0.45 0.26 0.17 0.07 19 17
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
235 238 240 240 327 340 376 367 391 598 613
Total Preferred & Common Equity
235 238 240 240 327 340 376 367 391 598 613
Total Common Equity
235 238 240 240 327 340 376 367 391 598 613
Common Stock
506 513 522 535 633 638 662 645 660 734 758
Retained Earnings
-271 -275 -282 -295 -306 -298 -285 -278 -269 -136 -131
Treasury Stock
- - - - - - - - - - -13
Accumulated Other Comprehensive Income / (Loss)
0.02 0.02 0.00 0.01 0.01 0.01 0.05 -0.06 0.13 0.08 -0.09

Annual Metrics And Ratios for Life360

This table displays calculated financial ratios and metrics derived from Life360's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - 78,400,518.00
DEI Adjusted Shares Outstanding
- - - - - 78,400,518.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - 1.92
Growth Metrics
- - - - - -
Profitability Metrics
- - - - - -
Net Operating Profit after Tax (NOPAT)
-12 -23 -66 -21 -5.58 87
Return On Investment Capital (ROIC_SIMPLE)
- - -26.21% -8.34% -1.56% 10.13%
Earnings before Interest and Taxes (EBIT)
-16 -34 -91 -28 -4.19 19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-8.66 -29 -79 -15 7.19 34
Valuation Ratios
- - - - - -
Leverage & Solvency
- - - - - -
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -64 -188 -40 -22 -78
Efficiency Ratios
- - - - - -
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 41 163 183 199 364
Increase / (Decrease) in Invested Capital
0.00 41 122 19 17 165
Book Value per Share
$0.00 $4.84 $3.92 $3.65 $4.80 $6.99
Tangible Book Value per Share
$0.00 $4.08 $0.93 $1.00 $2.47 $4.79
Total Capital
0.00 272 252 252 359 859
Total Debt
0.00 22 7.57 4.51 0.00 310
Total Long-Term Debt
0.00 8.28 4.06 1.06 0.00 310
Net Debt
0.00 -209 -81 -64 -159 -184
Capital Expenditures (CapEx)
0.65 0.08 0.70 2.22 5.13 7.51
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -2.03 -30 -4.90 4.41 15
Debt-free Net Working Capital (DFNWC)
0.00 229 59 64 164 509
Net Working Capital (NWC)
0.00 215 55 61 164 509
Net Nonoperating Expense (NNE)
4.68 11 26 7.18 -1.03 -64
Net Nonoperating Obligations (NNO)
0.00 -209 -81 -64 -159 -184
Total Depreciation and Amortization (D&A)
7.68 4.89 12 12 11 15
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($1.47) ($0.42) ($0.06) $1.95
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 62.21M 66.75M 72.13M 77.25M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.50) ($0.42) ($0.06) $1.77
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 62.84M 66.75M 72.13M 85.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 66.27M 68.29M 75.53M 80.20M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -23 -66 -21 -5.58 13
Debt Service Ratios
- - - - - -
Payout Ratios
- - - - - -

Quarterly Metrics And Ratios for Life360

This table displays calculated financial ratios and metrics derived from Life360's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - 78,400,518.00 80,198,613.00 81,031,691.00
DEI Adjusted Shares Outstanding
- - - - - - - - 78,400,518.00 80,198,613.00 81,031,691.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 1.65 0.03 0.06
Growth Metrics
- - - - - - - - - - -
Revenue Growth
21.90% 14.80% 19.88% 18.11% 32.85% 32.47% 35.96% 34.06% - 38.12% 37.77%
EBITDA Growth
100.62% 49.64% -131.07% 276.07% 16,354.39% 230.48% 542.93% 167.68% - -222.11% -60.46%
EBIT Growth
77.35% 39.96% -21.71% 144.14% 329.65% 149.67% 231.07% 517.02% - -634.50% -176.14%
NOPAT Growth
65.85% 57.16% 44.31% -182.16% 354.52% 151.54% 227.57% 142.43% - -345.69% -112.61%
Net Income Growth
74.43% 30.52% -148.45% 217.55% 370.09% 144.78% 163.90% 27.36% - -36.52% -27.76%
EPS Growth
77.78% 33.33% -114.29% 190.00% 450.00% 135.71% 153.33% 22.22% - -40.00% -25.00%
Operating Cash Flow Growth
515.11% 216.19% -11.41% 55.08% 37.56% 12.84% 309.69% 316.55% - 42.69% 78.71%
Free Cash Flow Firm Growth
0.00% 95.45% 250.91% -22.19% 59.70% -312.53% -576.67% -460.82% - -645.43% -187.11%
Invested Capital Growth
11.76% 2.17% -9.51% -1.24% 9.15% 20.84% 46.60% 35.88% - 117.55% 88.67%
Revenue Q/Q Growth
10.61% -10.05% 8.48% 9.43% 24.41% -10.30% 11.35% 7.90% - -1.96% 11.06%
EBITDA Q/Q Growth
101.74% -10,040.35% 59.83% 352.81% 63.00% -21.18% 36.36% -2.15% - -203.93% 143.51%
EBIT Q/Q Growth
59.25% -206.51% 39.81% 158.70% 112.05% -33.70% 58.84% -16.69% - -577.16% 75.65%
NOPAT Q/Q Growth
33.29% -46.95% 62.96% -676.99% 160.18% -70.24% -8.32% 158.44% - -105.68% 95.29%
Net Income Q/Q Growth
51.90% -210.78% -12.14% 170.13% 10.51% -48.48% 60.03% 39.78% - -97.86% 82.12%
EPS Q/Q Growth
60.00% -250.00% -7.14% 160.00% 55.56% -64.29% 60.00% 37.50% - -98.04% 100.00%
Operating Cash Flow Q/Q Growth
118.81% 19.31% -69.57% 95.23% 94.09% -2.13% 10.47% 98.51% - -53.24% 38.36%
Free Cash Flow Firm Q/Q Growth
-156.73% 63.54% 294.48% -167.12% 15.32% -273.21% -124.72% 21.04% - -281.23% 13.45%
Invested Capital Q/Q Growth
-0.20% -6.00% -3.34% 8.91% 10.29% 4.07% 17.27% 0.95% - 23.87% 1.70%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
69.15% 76.72% 74.98% 75.39% 74.01% 80.63% 78.44% 78.02% - 77.25% 79.83%
EBITDA Margin
0.07% -7.24% -2.68% 6.20% 8.12% 7.13% 8.74% 7.92% - -4.79% 1.87%
Operating Margin
-4.99% -8.15% -2.78% -5.33% 4.95% 2.11% 1.73% 4.57% - -5.64% -0.04%
EBIT Margin
-3.15% -10.72% -5.95% 3.19% 5.44% 4.02% 5.73% 4.43% - -8.89% -1.95%
Profit (Net Income) Margin
-3.62% -12.50% -12.92% 8.28% 7.35% 4.22% 6.07% 7.87% - 1.94% 3.18%
Tax Burden Percent
115.03% 116.63% 199.85% 259.59% 135.28% 105.14% 105.93% 95.82% - -31.21% 466.88%
Interest Burden Percent
100.00% 100.00% 108.72% 100.00% 100.00% 100.00% 100.00% 185.48% - 70.00% -34.99%
Effective Tax Rate
0.00% 0.00% 0.00% -159.59% -35.28% -5.14% -5.93% 4.18% - 0.00% -366.88%
Return on Invested Capital (ROIC)
-6.15% -10.57% -3.67% -26.10% 13.02% 4.65% 3.82% 9.43% - -6.35% -0.27%
ROIC Less NNEP Spread (ROIC-NNEP)
-6.00% -2.70% 4.99% -45.09% 12.34% 2.90% 0.38% 6.59% - -11.70% -4.11%
Return on Net Nonoperating Assets (RNNOA)
1.78% 0.77% -1.90% 16.82% -4.56% -1.12% -0.15% -2.75% - 3.79% 1.16%
Return on Equity (ROE)
-4.37% -9.80% -5.57% -9.28% 8.46% 3.54% 3.67% 6.69% - -2.56% 0.89%
Cash Return on Invested Capital (CROIC)
-23.24% -11.00% 2.13% -5.70% -11.67% -18.49% -34.47% -22.47% - -54.24% -42.01%
Operating Return on Assets (OROA)
-2.90% -10.54% -5.45% 2.94% 5.29% 4.12% 4.23% 3.34% - -6.28% -1.24%
Return on Assets (ROA)
-3.33% -12.29% -11.83% 7.63% 7.16% 4.33% 4.48% 5.94% - 1.37% 2.02%
Return on Common Equity (ROCE)
-4.37% -9.80% -5.57% -9.28% 8.46% 3.54% 3.67% 6.69% - -2.56% 0.89%
Return on Equity Simple (ROE_SIMPLE)
0.00% -9.96% -9.31% -4.77% 0.00% 2.55% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.04 -4.47 -1.65 -13 7.73 2.30 2.11 5.45 100 -5.65 -0.27
NOPAT Margin
-3.49% -5.71% -1.95% -13.84% 6.69% 2.22% 1.83% 4.38% - -3.95% -0.17%
Net Nonoperating Expense Percent (NNEP)
-0.15% -7.87% -8.65% 18.99% 0.68% 1.75% 3.45% 2.85% - 5.35% 3.83%
Return On Investment Capital (ROIC_SIMPLE)
-1.21% - - - 2.16% 0.61% 0.31% 0.78% 11.60% -0.62% -0.03%
Cost of Revenue to Revenue
30.85% 23.28% 25.03% 24.61% 25.99% 19.37% 21.56% 21.98% - 22.75% 20.17%
SG&A Expenses to Revenue
14.71% 18.41% 17.22% 16.40% 14.26% 15.10% 15.06% 16.07% - 15.61% 17.14%
R&D to Revenue
29.92% 34.84% 31.83% 31.24% 25.78% 29.34% 27.96% 26.03% - 27.44% 29.82%
Operating Expenses to Revenue
74.15% 84.87% 77.76% 80.72% 69.06% 78.51% 76.71% 73.45% - 82.89% 79.87%
Earnings before Interest and Taxes (EBIT)
-2.74 -8.38 -5.05 2.96 6.28 4.16 6.61 5.51 2.67 -13 -3.10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
0.06 -5.67 -2.28 5.75 9.38 7.39 10 9.86 6.59 -6.85 2.98
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 6.90 8.59 8.59 7.71 13.62 21.06 - 5.48 7.31
Price to Tangible Book Value (P/TBV)
0.00 0.00 15.08 17.82 16.72 14.60 26.35 38.02 - 9.56 12.38
Price to Revenue (P/Rev)
0.00 0.00 6.86 8.51 8.30 7.31 11.68 17.96 - 6.19 7.83
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 302.03 181.12 277.80 - 21.94 30.46
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.33% 0.55% 0.36% - 4.56% 3.28%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 12.62 15.26 14.66 13.16 20.02 32.98 - 6.93 9.44
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 6.37 8.04 7.87 6.88 11.39 17.64 - 5.91 7.57
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 406.38 134.85 149.36 208.77 - 145.66 256.08
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 326.60 243.25 328.66 - 811.66 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 3,805.88 714.90 477.51 - 47.96 63.51
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 77.59 94.31 89.61 80.35 110.55 126.22 - 33.35 41.54
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 563.01 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.02 0.02 0.00 0.00 0.00 0.00 0.84 0.79 - 0.52 0.51
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.84 0.79 - 0.52 0.51
Financial Leverage
-0.30 -0.28 -0.38 -0.37 -0.37 -0.38 -0.41 -0.42 - -0.32 -0.28
Leverage Ratio
1.35 1.35 1.27 1.28 1.26 1.26 1.67 1.66 - 1.54 1.84
Compound Leverage Factor
1.35 1.35 1.38 1.28 1.26 1.26 1.67 3.08 - 1.08 -0.64
Debt to Total Capital
1.79% 2.13% 0.00% 0.00% 0.00% 0.00% 45.76% 44.18% - 34.22% 33.68%
Short-Term Debt to Total Capital
1.37% 1.66% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Long-Term Debt to Total Capital
0.42% 0.47% 0.00% 0.00% 0.00% 0.00% 45.76% 44.18% - 34.22% 33.68%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital
98.21% 97.87% 100.00% 100.00% 100.00% 100.00% 54.24% 55.82% - 65.78% 66.32%
Debt to EBITDA
-0.29 -0.53 0.00 0.00 0.00 0.00 9.49 7.99 - 14.48 18.42
Net Debt to EBITDA
4.17 6.91 0.00 0.00 0.00 0.00 -3.78 -3.76 - -6.82 -9.14
Long-Term Debt to EBITDA
-0.07 -0.12 0.00 0.00 0.00 0.00 9.49 7.99 - 14.48 18.42
Debt to NOPAT
-0.21 -0.35 0.00 0.00 0.00 0.00 45.40 18.27 - 4.77 4.57
Net Debt to NOPAT
3.07 4.54 0.00 0.00 0.00 0.00 -18.12 -8.60 - -2.24 -2.27
Long-Term Debt to NOPAT
-0.05 -0.08 0.00 0.00 0.00 0.00 45.40 18.27 - 4.77 4.57
Altman Z-Score
0.00 0.00 17.21 20.23 22.68 22.47 8.54 13.34 - 5.27 7.06
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.86 1.78 2.81 2.76 3.12 3.38 7.14 6.80 - 5.37 5.60
Quick Ratio
1.57 1.49 2.59 2.44 2.81 2.98 6.74 6.37 - 5.03 5.26
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-22 -8.11 16 -11 -8.97 -33 -75 -59 -65 -249 -216
Operating Cash Flow to CapEx
930.22% 981.45% 263.53% 655.89% 669.36% 792.38% 485.89% 1,438.12% - 1,080.97% 2,490.59%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 35.86 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 7.39 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 4.59 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.92 0.98 0.92 0.92 0.97 1.03 0.74 0.76 - 0.71 0.63
Accounts Receivable Turnover
8.09 9.25 8.87 7.74 7.42 8.91 8.59 7.99 - 7.20 7.27
Inventory Turnover
10.97 10.81 10.92 7.21 15.19 11.84 12.86 7.33 - 9.80 10.52
Fixed Asset Turnover
542.33 437.25 254.99 265.62 296.12 241.85 178.42 185.21 - 192.95 198.22
Accounts Payable Turnover
8.32 8.65 10.15 5.57 16.26 12.90 15.05 7.32 - 8.91 13.86
Days Sales Outstanding (DSO)
45.13 39.46 41.14 47.14 49.21 40.95 42.48 45.69 - 50.71 50.17
Days Inventory Outstanding (DIO)
33.27 33.77 33.42 50.63 24.03 30.83 28.39 49.79 - 37.24 34.68
Days Payable Outstanding (DPO)
43.88 42.19 35.95 65.50 22.45 28.29 24.25 49.89 - 40.95 26.33
Cash Conversion Cycle (CCC)
34.52 31.04 38.61 32.26 50.79 43.48 46.62 45.59 - 46.99 58.52
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
183 172 166 181 199 207 243 246 364 451 459
Invested Capital Turnover
1.76 1.85 1.88 1.89 1.95 2.09 2.09 2.15 - 1.61 1.63
Increase / (Decrease) in Invested Capital
19 3.65 -17 -2.26 17 36 77 65 165 244 216
Enterprise Value (EV)
0.00 0.00 2,094 2,758 2,922 2,731 4,870 8,098 - 3,127 4,331
Market Capitalization
0.00 0.00 2,255 2,917 3,081 2,900 4,993 8,243 - 3,274 4,486
Book Value per Share
$3.65 $3.51 $4.69 $4.58 $4.80 $4.98 $4.79 $5.05 $6.99 $7.45 $7.57
Tangible Book Value per Share
$1.00 $0.91 $2.15 $2.21 $2.47 $2.63 $2.48 $2.80 $4.79 $4.27 $4.47
Total Capital
252 245 327 340 359 376 676 701 859 909 925
Total Debt
4.51 5.22 0.00 0.00 0.00 0.00 309 310 310 311 311
Total Long-Term Debt
1.06 1.16 0.00 0.00 0.00 0.00 309 310 310 311 311
Net Debt
-64 -68 -161 -159 -159 -169 -123 -146 -184 -146 -155
Capital Expenditures (CapEx)
0.96 1.09 1.23 0.97 1.84 1.52 2.74 1.84 1.41 1.59 0.96
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-4.90 -12 -20 -8.89 4.41 7.22 16 19 15 23 26
Debt-free Net Working Capital (DFNWC)
64 61 141 150 164 176 448 475 509 480 492
Net Working Capital (NWC)
61 57 141 150 164 176 448 475 509 480 492
Net Nonoperating Expense (NNE)
0.11 5.31 9.31 -21 -0.76 -2.08 -4.90 -4.34 -30 -8.43 -5.33
Net Nonoperating Obligations (NNO)
-64 -68 -161 -159 -159 -169 -123 -146 -184 -146 -155
Total Depreciation and Amortization (D&A)
2.79 2.72 2.77 2.79 3.10 3.23 3.47 4.35 3.92 5.87 6.08
Debt-free, Cash-free Net Working Capital to Revenue
-1.61% -3.79% -6.08% -2.59% 1.19% 1.82% 3.64% 4.21% - 4.33% 4.62%
Debt-free Net Working Capital to Revenue
21.04% 19.55% 42.84% 43.77% 44.05% 44.36% 104.88% 103.49% - 90.77% 86.01%
Net Working Capital to Revenue
19.90% 18.26% 42.84% 43.77% 44.05% 44.36% 104.88% 103.49% - 90.77% 86.01%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.04) ($0.14) ($0.15) $0.10 $0.13 $0.06 $0.09 $0.13 $1.67 $0.03 $0.06
Adjusted Weighted Average Basic Shares Outstanding
66.75M 68.54M 70.76M 74.23M 72.13M 75.70M 76.80M 77.74M 77.25M 80.15M 81.00M
Adjusted Diluted Earnings per Share
($0.04) ($0.14) ($0.15) $0.09 $0.14 $0.05 $0.08 $0.11 $1.53 $0.03 $0.06
Adjusted Weighted Average Diluted Shares Outstanding
66.75M 68.54M 70.76M 82.08M 72.13M 83.45M 84.48M 85.79M 85.17M 85.68M 85.59M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
68.29M 69.63M 74.14M 74.67M 75.53M 76.53M 77.55M 78.40M 80.20M 81.03M 81.48M
Normalized Net Operating Profit after Tax (NOPAT)
-3.04 -4.47 -1.65 -3.47 4.00 1.53 1.39 5.45 6.27 -5.65 -0.04
Normalized NOPAT Margin
-3.49% -5.71% -1.95% -3.73% 3.46% 1.48% 1.21% 4.38% - -3.95% -0.03%
Pre Tax Income Margin
-3.15% -10.72% -6.46% 3.19% 5.44% 4.02% 5.73% 8.21% - -6.22% 0.68%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 -11.47 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 -3.76 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 -14.27 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 -6.56 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -138.13% 0.00% 16.16% 12.04% - 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Life360’s financial profile has improved significantly over the period provided. Revenue increased from $57.2 million in Q3 2022 to $159.0 million in Q2 2026, while the company moved from substantial operating losses to approximately break-even operating income. However, recent cash usage, higher debt and continued dilution remain important considerations for investors.

  • Revenue growth remains strong. Q2 2026 revenue rose 37.8% year over year from $115.4 million to $159.0 million. Revenue has increased in every comparable period shown since 2022.
  • Gross margin has expanded. Gross profit reached $126.9 million in Q2 2026, representing an approximately 79.8% gross margin, compared with roughly 77.7% in Q2 2025 and 68.6% in Q2 2023. This suggests improving economics after direct costs.
  • Operating performance is nearing profitability. Life360 reported an operating loss of only $57,000 in Q2 2026, a major improvement from the $21.1 million operating loss in Q3 2022 and the $14.9 million loss in Q1 2023. The company was modestly profitable on an operating basis in Q3 and Q4 2025 before turning approximately breakeven in Q2 2026.
  • Operating cash flow has become consistently positive. Cash generated from operations increased from negative $16.4 million in Q3 2022 to $23.6 million in Q2 2026. Q1 and Q2 2026 produced $17.2 million and $23.8 million, respectively, indicating that the business is generating cash even as reported operating profits remain thin.
  • The company has substantial liquidity. At June 30, 2026, Life360 held $267.1 million in cash, $197.9 million in short-term investments and $1.0 million in restricted cash. This provides a sizable liquidity cushion for product development, acquisitions and debt obligations.
  • Shareholders’ equity has strengthened. Total equity increased to $613.4 million in Q2 2026 from $234.8 million in Q1 2023. Retained losses have also narrowed materially, improving from negative $305.9 million in Q2 2024 to negative $131.0 million in Q2 2026.
  • Investment and acquisition activity is affecting cash flow. Life360 purchased approximately $107.7 million of investments in Q2 2026 and spent $106.4 million on investments in Q1 2026. Q1 also included $55.6 million of acquisitions. These transactions may support long-term growth, but they make quarterly cash balances more volatile.
  • Reported earnings include unusual tax-related effects. Q4 2025 net income of $129.7 million was far above the company’s underlying quarterly results and included a $118.0 million income tax benefit. Q1 and Q2 2026 net income was much lower at $2.8 million and $5.1 million, respectively, so investors should focus on recurring operating results rather than the Q4 spike.
  • Net cash declined sharply in the first half of 2026. Cash and equivalents fell from $351.2 million at March 31, 2026, to $267.1 million at June 30, 2026. The company reported a negative $83.1 million change in cash during Q2, primarily reflecting investing activity and financing outflows.
  • Debt has increased substantially. Life360 had no long-term debt in Q2 2024, but reported $311.5 million of long-term debt in Q2 2026. Although cash and short-term investments exceed this debt, the increased leverage could raise interest, refinancing and execution risks.
  • Operating expenses continue to grow rapidly. Q2 2026 operating expenses increased 43.4% year over year to $127.0 million, exceeding the 37.8% revenue growth rate. Marketing expense was $52.3 million and research and development expense was $47.4 million, leaving little operating margin despite the company’s strong gross margin.
  • Share dilution remains a concern. Basic weighted-average shares increased from 66.5 million in Q2 2023 to 81.0 million in Q2 2026, while diluted shares reached 85.6 million. Continued growth in the share count can reduce the benefit of improving earnings for each individual shareholder.

Overall, the statements show a rapidly growing company with improving gross margins, positive operating cash flow and a considerably stronger equity base. The main issues are whether Life360 can convert its revenue growth into durable operating margins, control spending, manage its new debt load and limit dilution. Investors should also treat the unusually large Q4 2025 profit cautiously because it was heavily influenced by a tax benefit.

09/14/26 10:51 AM ETAI Generated. May Contain Errors.

Life360 Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Life360's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Life360's net income appears to be on a downward trend, with a most recent value of $150.83 million in 2025, falling from -$16.33 million in 2020. The previous period was -$4.56 million in 2024.

Life360's total operating income in 2025 was $18.83 million, based on the following breakdown:
  • Total Gross Profit: $380.84 million
  • Total Operating Expenses: $362.02 million

Over the last 5 years, Life360's total revenue changed from $80.66 million in 2020 to $489.48 million in 2025, a change of 506.9%.

Life360's total liabilities were at $411.51 million at the end of 2025, a 395.6% increase from 2024, and a 686.4% increase since 2021.

In the past 4 years, Life360's cash and equivalents has ranged from $68.96 million in 2023 to $494.26 million in 2025, and is currently $494.26 million as of their latest financial filing in 2025.

Over the last 5 years, Life360's book value per share changed from 0.00 in 2020 to 6.99 in 2025, a change of 699.2%.



Financial statements for OTCMKTS:LIFX last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners